Pic: Via Getty
Top 10 at 10: REE-nergised rare earths explorers, biotech standouts lead Wednesday’s winners
News
share
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.
WINNERS
Stocks highlighted in yellow made market-moving announcements (click headings to sort).
| Security | Description | Last | % | Volume | MktCap |
|---|---|---|---|---|---|
| DES | Desoto Resources | 0.13 | 71% | 1,973,098 | $4,554,414 |
| OD6 | OD6 Metals | 0.087 | 38% | 926,862 | $5,056,060 |
| COV | Cleo Diagnostics | 0.23 | 35% | 455,650 | $12,597,000 |
| OAR | OAR Resources Ltd | 0.002 | 33% | 1,447,500 | $4,729,966 |
| TX3 | Trinex Minerals Ltd | 0.004 | 33% | 3,997,250 | $5,485,957 |
| BEZ | Besra Gold Inc | 0.11 | 24% | 1,654,058 | $37,210,981 |
| VTI | Vision Tech Inc | 0.135 | 23% | 71,915 | $6,023,147 |
| 8IH | 8I Holdings Ltd | 0.012 | 20% | 30,100 | $3,573,560 |
| CAV | Carnavale Resources | 0.006 | 20% | 4,471 | $17,117,759 |
| LRL | Labyrinth Resources | 0.006 | 20% | 100,000 | $5,937,719 |
Desoto Resources (ASX:DES) is buying a rare earths project in the Northern Territory called Spectrum, where previous drilling pulled up a highlight 6m @ 6.55% total rare earths (TREO) from 248m.
OD6 Metals (ASX:OD6) doubles the resource at its Splinter Rock project to 682Mt @ 1,338ppm TREO.
“This mineral resource estimate sets OD6 apart from any other clay hosted rare earth project in Australia, and highlights Splinter Rock to be one of the largest and highest-grade projects globally,” MD Brett Hazelden says.
Oar Resources (ASX:OAR) increases its uranium exploration ground by 283% to 880sqkm in the Brazilian states of Rio Grande Do Sul and Goiás.
Cleo Diagnostic’s (ASX:COV) ovarian cancer blood test outperforms the current clinical benchmark, correctly detecting 90% of early-stage cancers compared to only 50% using standard workflows.
Genetic Technologies (ASX:GTG) releases its novel Comprehensive Risk Assessment test that covers 100% of women at risk of developing breast and ovarian cancer.
“… in preparation for significant demand for this revolutionary test we have fully onboarded a high throughput automated laboratory in the United States with capacity to scale up to run 100,000 tests per month should future demand require,” GTG chair Peter Rubinstein says.
LOSERS
Stocks highlighted in yellow made market-moving announcements (click headings to sort).
| Security | Description | Last | % | Volume | MktCap |
|---|---|---|---|---|---|
| 88E | 88 Energy Ltd | 0.002 | -33% | 977999 | $86,678,016 |
| TKL | Traka Resources | 0.001 | -33% | 322518 | $2,625,988 |
| AVE | Avecho Biotech Ltd | 0.003 | -25% | 220000 | $12,677,188 |
| SFG | Seafarms Group Ltd | 0.003 | -25% | 20000 | $19,346,397 |
| AIV | Activex Limited | 0.004 | -20% | 9822 | $1,077,513 |
| 1MC | Morella Corporation | 0.0025 | -17% | 2901833 | $18,536,398 |
| MTL | Mantle Minerals Ltd | 0.0025 | -17% | 1050000 | $18,592,338 |
| PNT | Panther Metals | 0.05 | -15% | 169491 | $5,142,804 |
| MCL | Mighty Craft Ltd | 0.006 | -14% | 48950 | $2,582,365 |
| TSL | Titanium Sands Ltd | 0.006 | -14% | 4475000 | $15,482,230 |
Read MoreRare Earths
